Wikidata

(Q65376346)

English

A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Clinical Outcomes Study to Evaluate the Effects of IL-6 Receptor Blockade With Tocilizumab (TCZ) in Comparison With Etanercept (ETA) on the Rate of Cardiovascular Events in Patients With Moderate to Severe Rheumatoid Arthritis (RA) (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Argentina
0 references
Austria
0 references
Belgium
0 references
Bosnia and Herzegovina
0 references
Canada
0 references
Chile
0 references
Croatia
0 references
Ecuador
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
India
0 references
Israel
0 references
Italy
0 references
Latvia
0 references
Lithuania
0 references
Malaysia
0 references
Mexico
0 references
Netherlands
0 references
Philippines
0 references
Poland
0 references
Romania
0 references
Serbia
0 references
South Africa
0 references
Spain
0 references
Turkey
0 references
United Kingdom
0 references
start time
2 August 2011
0 references
end time
25 March 2016
0 references
number of participants
3,080
0 references
minimum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65376346&oldid=2237351594"